MedBright AI Investments Inc. has appointed Brandon Kou as a Director, effective February 3, 2025, replacing Jaime Gerber. Kou is a Managing Director at Wildcat Equity Partners and has a background in investment banking and leadership roles in various industries, including healthcare, media, and technology. He co-founded Block Partners and Mavan Capital Partners and previously served as CEO of Leef Brands, where he led significant mergers and acquisitions. MedBright AI focuses on investing in diversified industries such as technology, healthcare, and artificial intelligence, aiming for high-quality opportunities with strong return potentials.
The company also announced the granting of 1,250,000 options to certain directors and officers at $0.035 for five years. MedBright AI expressed appreciation for Dr. Jamie Gerber's contributions and wished him well in his future endeavors. The company is committed to governance and seeks near-term and midterm investment opportunities. For further information, interested parties can contact MedBright AI's Interim CEO, Christopher Cherry.
Key takeaways:
Brandon Kou has been appointed as a Director at MedBright AI, replacing Jaime Gerber.
Brandon Kou has a background in investment banking and has co-founded several companies, including Block Partners and Mavan Capital Partners.
MedBright AI is focused on investing in diversified industries such as technology, healthcare, and artificial intelligence.
The company has granted 1,250,000 options to certain directors and officers at $0.035 for five years.
